• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血流感染后心肌梗死和中风的风险:一项基于人群的自我对照病例系列研究。

Risk of myocardial infarction and stroke following bloodstream infection: a population-based self-controlled case series.

作者信息

Underwood Jonathan, Reeve Nicola, Best Victoria, Akbari Ashley, Ahmed Haroon

机构信息

Infection and Immunity, Cardiff University, Cardiff, UK

Infectious Diseases, Cardiff and Vale University Health Board, Cardiff, UK.

出版信息

Open Heart. 2025 Mar 25;12(1):e003241. doi: 10.1136/openhrt-2025-003241.

DOI:10.1136/openhrt-2025-003241
PMID:40132892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11938248/
Abstract

BACKGROUND

Cardiovascular disease (CVD) events triggered by inflammation are an underappreciated and poorly quantified cause of morbidity and mortality in patients with bloodstream infections (BSIs). We aimed to determine the risk of myocardial infarction (MI) and stroke after BSI.

METHODS

This self-controlled case series study was conducted within the Secure Anonymised Information Linkage Databank, containing anonymised population-scale electronic health record data for Wales, UK. We included adults with community-acquired BSI between 2010 and 2020. MI and stroke were determined from International Classification of Disease Version 10 coded admissions. Predefined risk periods after BSI were compared with the baseline period using pseudo-Poisson regression adjusted for age. Maximum C-reactive protein (CRP), a proxy for the magnitude of the inflammatory response, was determined within the first 7 days after BSI.

RESULTS

We identified 50 450 individuals with MI and 56 890 with stroke, of whom 1000 and 1290, respectively, also had at least one community-associated BSI. The risk of MI was most elevated in the first 1-7 days after BSI (adjusted incidence rate ratio (IRR) (95% CI): 9.67 (6.54 to 14.3)) and returned to baseline after 28 days. The risk was similarly elevated for stroke.The largest magnitude of risk was observed for those with a maximal CRP>300 mg/L (MI IRR: 21.54 (9.57 to 48.52); stroke IRR: 6.94 (3.14 to 15.32)).

CONCLUSION

BSI is associated with an increased risk of CVD events in the first 2 weeks after infection. Greater systemic inflammation was associated with a higher risk of CVD events and suggests targeting the inflammatory response caused by BSI warrants further study.

摘要

背景

炎症引发的心血管疾病(CVD)事件是血流感染(BSI)患者发病和死亡的一个未得到充分认识且量化不足的原因。我们旨在确定BSI后心肌梗死(MI)和中风的风险。

方法

这项自我对照病例系列研究在安全匿名信息链接数据库中进行,该数据库包含英国威尔士的匿名人口规模电子健康记录数据。我们纳入了2010年至2020年间社区获得性BSI的成年人。MI和中风通过国际疾病分类第10版编码的入院记录确定。使用针对年龄调整的伪泊松回归,将BSI后的预定义风险期与基线期进行比较。在BSI后的前7天内测定最大C反应蛋白(CRP),作为炎症反应程度的指标。

结果

我们确定了50450例MI患者和56890例中风患者,其中分别有1000例和1290例也至少有一次社区相关性BSI。MI风险在BSI后的前1至7天最高(调整后的发病率比(IRR)(95%CI):9.67(6.54至14.3)),28天后恢复到基线水平。中风风险同样升高。最大CRP>300mg/L的患者风险最高(MI IRR:21.54(9.57至48.52);中风IRR:6.94(3.14至15.32))。

结论

BSI与感染后前2周内CVD事件风险增加相关。更强的全身炎症与更高的CVD事件风险相关,提示针对BSI引起的炎症反应进行干预值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfef/11938248/89180d256148/openhrt-12-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfef/11938248/0655cd9d7519/openhrt-12-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfef/11938248/89180d256148/openhrt-12-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfef/11938248/0655cd9d7519/openhrt-12-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfef/11938248/89180d256148/openhrt-12-1-g002.jpg

相似文献

1
Risk of myocardial infarction and stroke following bloodstream infection: a population-based self-controlled case series.血流感染后心肌梗死和中风的风险:一项基于人群的自我对照病例系列研究。
Open Heart. 2025 Mar 25;12(1):e003241. doi: 10.1136/openhrt-2025-003241.
2
Risk of myocardial infarction and stroke following microbiologically confirmed urinary tract infection: a self-controlled case series study using linked electronic health data.微生物学确诊的尿路感染后心肌梗死和中风的风险:一项使用关联电子健康数据的自我对照病例系列研究。
BMJ Open. 2025 Jun 30;15(6):e097754. doi: 10.1136/bmjopen-2024-097754.
3
Smoking cessation for secondary prevention of cardiovascular disease.戒烟对心血管疾病二级预防的作用。
Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2.
4
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
5
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复
Cochrane Database Syst Rev. 2016 Jan 5;2016(1):CD001800. doi: 10.1002/14651858.CD001800.pub3.
6
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.用于心血管疾病一级和二级预防的饮食预防高血压(DASH)方案。
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2.
7
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.氯吡格雷和双嘧达莫缓释制剂预防闭塞性血管事件(技术评估 90 号回顾):系统评价和经济分析。
Health Technol Assess. 2011 Sep;15(31):1-178. doi: 10.3310/hta15310.
8
Sex differences in myocardial infarction care and outcomes: a longitudinal Scottish National Data-Linkage Study.心肌梗死护理与结局的性别差异:一项苏格兰全国性纵向数据关联研究
Eur J Prev Cardiol. 2025 Jun 3;32(8):696-707. doi: 10.1093/eurjpc/zwae333.
9
Psychological interventions for coronary heart disease.冠心病的心理干预措施。
Cochrane Database Syst Rev. 2017 Apr 28;4(4):CD002902. doi: 10.1002/14651858.CD002902.pub4.
10
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复。
Cochrane Database Syst Rev. 2021 Nov 6;11(11):CD001800. doi: 10.1002/14651858.CD001800.pub4.

引用本文的文献

1
Distribution and Antimicrobial Resistance Analysis of Blood Culture Isolates at a Chinese National Cardiovascular Regional Medical Center: A 7-Year Retrospective Study.中国国家心血管区域医疗中心血培养分离株的分布及耐药性分析:一项7年回顾性研究
Infect Drug Resist. 2025 Aug 22;18:4249-4262. doi: 10.2147/IDR.S545293. eCollection 2025.

本文引用的文献

1
Adjunctive Statin Therapy in Patients with Covid-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.新冠病毒病患者的辅助他汀类药物治疗:随机对照试验的系统评价和荟萃分析
Am J Med. 2024 Oct;137(10):966-973.e11. doi: 10.1016/j.amjmed.2024.06.002. Epub 2024 Jun 10.
2
All-cause and Infection-attributable Mortality Amongst Adults With Bloodstream Infection-a Population-based Study.成人血流感染的全因死亡率和感染归因死亡率——一项基于人群的研究
Open Forum Infect Dis. 2024 Mar 6;11(5):ofae126. doi: 10.1093/ofid/ofae126. eCollection 2024 May.
3
Simvastatin in Critically Ill Patients with Covid-19.
辛伐他汀用于新冠肺炎危重症患者
N Engl J Med. 2023 Dec 21;389(25):2341-2354. doi: 10.1056/NEJMoa2309995. Epub 2023 Oct 25.
4
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.2019 年与 33 种细菌病原体相关的全球死亡率:2019 年全球疾病负担研究的系统分析。
Lancet. 2022 Dec 17;400(10369):2221-2248. doi: 10.1016/S0140-6736(22)02185-7. Epub 2022 Nov 21.
5
Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials.肝素全剂量抗凝治疗住院非危重症 COVID-19 患者的疗效和安全性:多中心随机对照试验的荟萃分析。
J Thromb Thrombolysis. 2022 Oct;54(3):420-430. doi: 10.1007/s11239-022-02681-x. Epub 2022 Aug 3.
6
Outcomes of Hospitalizations With Septic Shock Complicated by Types 1 and 2 Myocardial Infarction.伴有 1 型和 2 型心肌梗死的脓毒性休克住院患者的结局。
Am J Cardiol. 2022 Jul 1;174:27-33. doi: 10.1016/j.amjcard.2022.03.027. Epub 2022 May 4.
7
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.COVID-19 患者住院期间使用阿司匹林(RECOVERY):一项随机、对照、开放标签、平台试验。
Lancet. 2022 Jan 8;399(10320):143-151. doi: 10.1016/S0140-6736(21)01825-0. Epub 2021 Nov 17.
8
Avoiding bias in self-controlled case series studies of coronavirus disease 2019.避免 2019 冠状病毒病的自身对照病例系列研究中的偏倚。
Stat Med. 2021 Nov 30;40(27):6197-6208. doi: 10.1002/sim.9179. Epub 2021 Sep 1.
9
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.COVID-19 重症患者的白细胞介素 6 受体拮抗剂。
N Engl J Med. 2021 Apr 22;384(16):1491-1502. doi: 10.1056/NEJMoa2100433. Epub 2021 Feb 25.
10
Infection as a Stroke Risk Factor and Determinant of Outcome After Stroke.感染作为卒中的危险因素及卒中后结局的决定因素。
Stroke. 2020 Oct;51(10):3156-3168. doi: 10.1161/STROKEAHA.120.030429. Epub 2020 Sep 8.